Lion Street Advisors’s ResMed RMD Stock Holding History

Lion Street Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-40	Closed	-$6K	–	322
2020 Q1	$6K	Buy	+40	New	+$6.37K	0.03%	234

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Lion Street Advisors's RMD Position: Q2 2020 in Review

Lion Street Advisors sold out of ResMed (RMD) in Q2 2020, closing a stake of 40 shares — an estimated $6K sold.

Lion Street Advisors first reported a position in RMD in Q1 2020 and held it in 1 quarter. The position peaked at $6K in Q1 2020. 582 funds tracked by Wall St. Rank hold RMD as of Q2 2020.

Lion Street Advisors reported no remaining ResMed position as of Q2 2020 after selling out during the quarter.
Lion Street Advisors sold 40 ResMed shares in Q2 2020, an estimated $6K.
Lion Street Advisors first reported a position in ResMed in Q1 2020 and held it in 1 quarter.
Lion Street Advisors's ResMed position peaked at $6K in Q1 2020.
582 funds tracked by Wall St. Rank held ResMed as of Q2 2020.

Based on Lion Street Advisors's 13F filing for Q2 2020, filed 20 Jul 2020.